New scan aims to forecast pancreatic Cancer's response to chemo
NCT ID NCT04700488
Summary
This study is testing whether a special type of MRI scan can predict how well a patient's pancreatic cancer will respond to chemotherapy given before surgery. Researchers will scan 36 patients with pancreatic cancer who are scheduled for chemotherapy. The goal is to see if the scan's images can forecast which patients will have better outcomes, like longer survival without the cancer worsening.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Conditions
Explore the condition pages connected to this study.